Sustanon's 'blend advantage' for muscle growth: fact or fitness myth?

What did @fissionfusiontraining actually say?

The creator says Sustanon is their preferred testosterone for both TRT and "big cycles," and that its four esters produce intentional blood level fluctuations. Their core argument: "just like with heart rate variability, if you have variance and variability and some volatility in the system and this applies to hormones as well, you will get better results than if you did not." This is the load-bearing claim. Everything else is personal testimony.

To be fair, they correctly identify that Sustanon contains four testosterone esters with different half-lives, which is factually accurate. They also acknowledge this is a minority view, noting "a lot of folks actually don't like Sustanon" because of unstable blood levels. That self-awareness is worth crediting. But crediting the instability itself as a feature, not a bug, requires actual evidence, and that evidence does not exist in any peer-reviewed form.

Does the science back this up?

No. The heart rate variability analogy is a creative stretch, and the hormonal evidence points in the opposite direction.

Heart rate variability (HRV) reflects autonomic nervous system resilience, a well-studied biomarker for cardiac and recovery health. Applying that framework to exogenous testosterone pharmacokinetics is not a supported extrapolation. HRV variability is a passive readout of a healthy regulatory system. Testosterone blood level swings from a multi-ester compound are pharmacologically imposed fluctuations, not a sign of system health.

Studies on TRT consistently show that stable serum testosterone is associated with better symptomatic outcomes. Ramasamy et al. (2014, Journal of Urology) found that testosterone pellets and other delivery methods producing stable levels correlated with improved quality-of-life scores versus injection protocols with high peak-to-trough variation. Zitzmann et al. (2006, European Journal of Endocrinology) documented that mood instability and libido disruption in hypogonadal men on injections were linked directly to the trough-to-peak swing, not improved by it. The idea that hormonal oscillation produces "better results" than steady-state levels is not supported by clinical data in TRT populations.

What did they get wrong (or right)?

They got the pharmacology of Sustanon right. They got the implication wrong.

Sustanon 250 does contain four esters: testosterone propionate, phenylpropionate, isocaproate, and decanoate. That is accurate. The half-lives differ, which does produce a more complex absorption curve than single-ester compounds like testosterone cypionate or enanthate. So far, so correct.

Where this breaks down is the leap from "variable blood levels" to "better results." The creator offers no mechanistic explanation for why hormonal volatility would improve anabolic outcomes or TRT efficacy. The HRV analogy is scientifically unrelated. HRV and testosterone pharmacokinetics are governed by entirely different physiological systems. Citing one to validate the other is not evidence, it is pattern-matching.

Also worth flagging: the creator is explicitly recommending Sustanon for "big cycles," meaning supraphysiologic use for muscle gain. Using TRT language to discuss performance-enhancement cycles conflates two very different clinical contexts, which is misleading to viewers who may be seeking actual hormone therapy guidance.

What should you actually know?

Sustanon is a legitimate pharmaceutical testosterone product, but its multi-ester design was a practical solution, not a performance innovation.

Sustanon was originally developed by Organon to reduce injection frequency while maintaining adequate testosterone levels, particularly in clinical settings with limited access to frequent injections. It was not designed to produce beneficial hormonal variability. The fluctuation is a pharmacokinetic side effect of the formulation, not an intended therapeutic feature.

For legitimate TRT under medical supervision, most evidence-based protocols favor minimizing peak-to-trough variation, which is why many clinicians now prefer twice-weekly or more frequent injections of single-ester compounds. The goal is physiologic simulation, not volatility. If you are considering testosterone therapy of any kind, that decision belongs with a licensed physician who can assess your baseline levels, symptoms, and health history, not a TikTok recommendation from someone running "big cycles."

• Sustanon's four esters are real, and the pharmacokinetics the creator describes are accurate in a basic sense.
• The claim that hormonal variability produces better anabolic or TRT outcomes is not supported by clinical evidence.
• The HRV analogy does not translate to testosterone pharmacokinetics by any established mechanism.
• Conflating TRT with anabolic cycle recommendations misleads viewers with different health needs.